131 related articles for article (PubMed ID: 21515048)
1. A novel, broad-spectrum antitumor compound containing the 1-hydroxycyclohexa-2,5-dien-4-one group: the disclosure of a new antitumor pharmacophore in protoapigenone 1.
Yuan Q; Liu Z; Xiong C; Wu L; Wang J; Ruan J
Bioorg Med Chem Lett; 2011 Jun; 21(11):3427-30. PubMed ID: 21515048
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of antitumour (1H-1,2,3-triazol-4-yl)-4-hydroxycyclohexa-2,5-dien-1-ones by copper-catalysed Huisgen cycloadditions.
McCarroll AJ; Matthews CS; Wells G; Bradshaw TD; Stevens MF
Org Biomol Chem; 2010 May; 8(9):2078-84. PubMed ID: 20401384
[TBL] [Abstract][Full Text] [Related]
3. Quinols as novel therapeutic agents. 2.(1) 4-(1-Arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and related agents as potent and selective antitumor agents.
Berry JM; Bradshaw TD; Fichtner I; Ren R; Schwalbe CH; Wells G; Chew EH; Stevens MF; Westwell AD
J Med Chem; 2005 Jan; 48(2):639-44. PubMed ID: 15658878
[TBL] [Abstract][Full Text] [Related]
4. Direct semi-synthesis of the anticancer lead-drug protoapigenone from apigenin, and synthesis of further new cytotoxic protoflavone derivatives.
Hunyadi A; Chuang DW; Danko B; Chiang MY; Lee CL; Wang HC; Wu CC; Chang FR; Wu YC
PLoS One; 2011; 6(8):e23922. PubMed ID: 21912610
[TBL] [Abstract][Full Text] [Related]
5. First total synthesis of protoapigenone and its analogues as potent cytotoxic agents.
Lin AS; Nakagawa-Goto K; Chang FR; Yu D; Morris-Natschke SL; Wu CC; Chen SL; Wu YC; Lee KH
J Med Chem; 2007 Aug; 50(16):3921-7. PubMed ID: 17622129
[TBL] [Abstract][Full Text] [Related]
6. Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2.
Chang HL; Wu YC; Su JH; Yeh YT; Yuan SS
J Pharmacol Exp Ther; 2008 Jun; 325(3):841-9. PubMed ID: 18337475
[TBL] [Abstract][Full Text] [Related]
7. Enantioselective total synthesis of (+)-ottelione A, (-)-ottelione B, (+)-3-epi-ottelione A and preliminary evaluation of their antitumor activity.
Araki H; Inoue M; Suzuki T; Yamori T; Kohno M; Watanabe K; Abe H; Katoh T
Chemistry; 2007; 13(35):9866-81. PubMed ID: 17879247
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo antitumor activity of Macrothelypteris torresiana and its acute/subacute oral toxicity.
Huang XH; Xiong PC; Xiong CM; Cai YL; Wei AH; Wang JP; Liang XF; Ruan JL
Phytomedicine; 2010 Oct; 17(12):930-4. PubMed ID: 20381325
[TBL] [Abstract][Full Text] [Related]
9. Flavonoids from the aerial parts of Macrothelypteris torresiana.
Fang W; Ruan J; Cai Y; Wei A; Zhou D; Zhang W
Nat Prod Res; 2011 Jan; 25(1):36-9. PubMed ID: 21240759
[TBL] [Abstract][Full Text] [Related]
10. Protoapigenone, a novel flavonoid, inhibits ovarian cancer cell growth in vitro and in vivo.
Chang HL; Su JH; Yeh YT; Lee YC; Chen HM; Wu YC; Yuan SS
Cancer Lett; 2008 Aug; 267(1):85-95. PubMed ID: 18430509
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of baicalein derivatives as potent antitumor agents.
Luo R; Wang J; Zhao L; Lu N; You Q; Guo Q; Li Z
Bioorg Med Chem Lett; 2014 Mar; 24(5):1334-8. PubMed ID: 24507925
[TBL] [Abstract][Full Text] [Related]
12. Asymmetrical 2,6-bis(benzylidene)cyclohexanones: Synthesis, cytotoxic activity and QSAR study.
Nakhjiri M; Safavi M; Alipour E; Emami S; Atash AF; Jafari-Zavareh M; Ardestani SK; Khoshneviszadeh M; Foroumadi A; Shafiee A
Eur J Med Chem; 2012 Apr; 50():113-23. PubMed ID: 22341788
[TBL] [Abstract][Full Text] [Related]
13. Protoapigenone derivatives: albumin binding properties and effects on HepG2 cells.
Poór M; Li Y; Kunsági-Máté S; Varga Z; Hunyadi A; Dankó B; Chang FR; Wu YC; Kőszegi T
J Photochem Photobiol B; 2013 Jul; 124():20-6. PubMed ID: 23648796
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro antitumor activity of new butenolide-containing dithiocarbamates.
Wang XJ; Xu HW; Guo LL; Zheng JX; Xu B; Guo X; Zheng CX; Liu HM
Bioorg Med Chem Lett; 2011 May; 21(10):3074-7. PubMed ID: 21486694
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and in vitro antitumor evaluation of novel diaryl ureas derivatives.
Sun M; Wu X; Chen J; Cai J; Cao M; Ji M
Eur J Med Chem; 2010 Jun; 45(6):2299-306. PubMed ID: 20181414
[TBL] [Abstract][Full Text] [Related]
16. Quinols as novel therapeutic agents. 7.1 Synthesis of antitumor 4-[1-(arylsulfonyl-1H-indol-2-yl)]-4-hydroxycyclohexa-2,5-dien-1-ones by Sonogashira reactions.
McCarroll AJ; Bradshaw TD; Westwell AD; Matthews CS; Stevens MF
J Med Chem; 2007 Apr; 50(7):1707-10. PubMed ID: 17343370
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumor evaluation of novel cyclic arylsulfonylureas: ADME-T and pharmacophore prediction.
El-Deeb IM; Bayoumi SM; El-Sherbeny MA; Abdel-Aziz AA
Eur J Med Chem; 2010 Jun; 45(6):2516-30. PubMed ID: 20236733
[TBL] [Abstract][Full Text] [Related]
18. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
19. Antitumor agents 260. New desmosdumotin B analogues with improved in vitro anticancer activity.
Nakagawa-Goto K; Bastow KF; Chen TH; Morris-Natschke SL; Lee KH
J Med Chem; 2008 Jun; 51(11):3297-303. PubMed ID: 18473435
[TBL] [Abstract][Full Text] [Related]
20. Less Cytotoxic Protoflavones as Antiviral Agents: Protoapigenone 1'-
Vágvölgyi M; Girst G; Kúsz N; Ötvös SB; Fülöp F; Hohmann J; Servais JY; Seguin-Devaux C; Chang FR; Chen MS; Chang LK; Hunyadi A
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31842358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]